Investigation of the HSPG2 Gene in Tardive Dyskinesia - New Data and Meta-Analysis

• Main Authors: Clement C. Zai (Author), Frankie H. Lee (Author), Arun K. Tiwari (Author), Justin Y. Lu (Author), Vincenzo de Luca (Author), Miriam S. Maes (Author), Deanna Herbert (Author), Anashe Shahmirian (Author), Sheraz Y. Cheema (Author), Gwyneth C. Zai (Author), Anupama Atukuri (Author), Michael Sherman (Author), Sajid A. Shaikh (Author), Maria Tampakeras (Author), Natalie Freeman (Author), Nicole King (Author), Daniel J. Müller (Author), Lior Greenbaum (Author), Bernard Lerer (Author), Aristotle N. Voineskos (Author), Steven G. Potkin (Author), Jeffrey A. Lieberman (Author), Herbert Y. Meltzer (Author), Gary Remington (Author), James L. Kennedy (Author)
• Format: Book
• Published: Frontiers Media S.A., 2018-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Tardive dyskinesia (TD) is a movement disorder that may occur after extended use of antipsychotic medications. The etiopathophysiology is unclear; however, genetic factors play an important role. The Perlecan (HSPG2) gene was found to be significantly associated with TD in Japanese schizophrenia pat...